Didanosine
| CAS No. | 69655-05-6 | Cat. No. | BCP13023 |
| Name | Didanosine | ||
| Synonyms | DdI;Videx;2',3'-Dideoxyinosine;Dideoxyinosine; Videx EC; | ||
| Formula | C10H12N4O3 | M. Wt | 236.23 |
| Description | Didanosine (2′,3′-dideoxyinosine, ddI, DDI) marketed under the trade names Videx and Videx EC. It is an antiretroviral medication used to treat HIV/AIDS in combination with other medications as part of highly active antiretroviral therapy (HAART). It is of the reverse transcriptase inhibitor class. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system. (Source: https://en.wikipedia.org/wiki/Didanosine). | ||
| Pathways | Microbiology/Virology | ||
| Targets | Reverse Transcriptase HIV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.